Search

everythinglearnresearchcommunity

for

Search:↓

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

CXCR2 in skin cells promotes tumor growth.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

ERK activation spreads between cells, influencing cell division and wound healing.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Lack of KSR1 stops certain skin tumors in mice.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

VEGF promotes hair follicle cell growth through the VEGFR-2/ERK pathway.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

ERG increases SOX9, promoting prostate cancer growth and invasion.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

QLT0267 stops hair follicle cell growth and movement.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.